Find Academic Supervisors

• Substance use prevention
• Mental health promotion
• Healthy lifestyles and chronic disease prevention
• +4 more

Professor Nicola Newton is the Director of Prevention Research at the Matilda Centre for Research in Mental Health and Substance Use, University of Sydney. She leads internationally recognized programs in substance use and mental health prevention, with a focus on school-based and eHealth interventions. Her roles include co-Director of the NHMRC Centre for Research Excellence - PREMISE and Vice President of the Alliance for the Prevention of Mental Disorders. She holds a Bachelor of Psychology (Hons Class 1) from Macquarie University and a PhD from the National Drug and Alcohol Research Centre (UNSW). After postdoctoral work at King’s College London and 7 years at NDARC, she joined the Matilda Centre in 2018. Research Interests: Substance use prevention, mental health promotion, healthy lifestyles, adolescent health, personality-targeted interventions, eHealth technologies, translation and implementation science. Methodological Expertise: Cluster randomized controlled trials, school-based trials, intervention development, online clinical trials. Her recent publications focus on eHealth interventions for vaping, mental health disparities among gender/sexuality diverse youth, trauma-informed prevention, and socioeconomic factors in substance use. She has received 34 awards, including the 2024 Australian Rotary Health Mental Health Impact Award, and serves as Assistant Editor for Drug & Alcohol Review and Addiction . Grants: >$51 million as Chief Investigator, including funding from NHMRC, MRFF, Movember Foundation, and Australian Government Department of Health. She advises state and federal health/education departments on substance use prevention.

Francois JeanView profile

Professor

• Cellular virology
• Emerging human viruses
• Host-virus interactions
• +20 more

Dr. François Jean is a Professor in the Department of Microbiology and Immunology at the University of British Columbia (UBC), with a research focus on cellular virology and host-virus interactions . As a leading expert in emerging human viruses , he investigates broad-spectrum antiviral agents targeting SARS-CoV-2, influenza A virus, and flaviviruses like dengue and zika. His lab employs high-content screening and AI-based image analysis to evaluate antiviral efficacy in 2D and 3D cell models derived from patients. Key Research Areas: Host-Directed Antivirals (HDAs), Proteomics, Viral Pathogenesis, Molecular Diagnostics Affiliations: Life Sciences Institute, CoVaRR-Net Pillar 10, FINDER (UBC Facility for Infectious Disease and Epidemic Research) Dr. Jean’s publications emphasize novel antiviral compounds such as N-0385 and cladoniamide A , derived from natural sources like B.C. sea sponges. His work has led to 25 invention disclosures and patents at UBC, with funding from CIHR , Genome BC , and CoVaRR-Net . Current students include PhD candidate Connor Thompson, and former trainees are listed in the lab’s alumni.

Karthik AkkirajuView profile

Assistant Professor

• Heterogeneous Catalysis
• Density Functional Theory
• Material Poverty
• +7 more

Dr. Karthik Akkiraju serves as Assistant Professor in the Department of Materials Engineering within UBC's Faculty of Applied Science, maintaining an active research program at the intersection of materials science and socio-environmental systems. His office (FF 011) and contact email (karthik.akkiraju@ubc.ca) reflect his current institutional affiliation. His research pioneers a techno-social paradigm for planetary health through three synergistic foci: (1) Establishing material poverty benchmarks using household survey data to identify resource-deprived communities; (2) Quantifying socio-environmental impacts across material supply chains; (3) Integrating well-being metrics into heterogeneous catalyst design frameworks. This work fundamentally reimagines materials engineering by centering human well-being within ecological boundaries, developing design methodologies that balance material requirements with equitable environmental constraints. Analysis of his publication trajectory reveals consistent interdisciplinary innovation spanning computational catalysis, environmental policy, and social metrics. His recent work demonstrates particular strength in perovskite catalyst engineering for sustainable chemistry and novel methodologies for spatial well-being assessment, reflecting a unique fusion of traditional materials science with computational social science. Dr. Akkiraju directs the Sustainable Materials Lab (SMAL), where his team develops frameworks connecting material consumption patterns to human development outcomes, creating pathways for resource allocation that simultaneously address poverty alleviation and environmental sustainability.

Alexander MeeskeView profile

Assistant Professor

• CRISPR-Cas Systems
• Bacterial Immunity
• Bacteriophage Interactions
• +4 more

Alexander Meeske is an Assistant Professor at the University of Washington in the Department of Microbiology . His research focuses on the mechanistic relationships between CRISPR-Cas systems, bacterial hosts, and bacteriophages , utilizing high-throughput genetics, biochemical reconstitution, and microscopy. Established Listeria seeligeri as a model for RNA-targeting CRISPR-Cas13 immunity during postdoctoral work at Rockefeller University. Current work explores regulation of CRISPR immunity, phage resistance mechanisms, and non-immune roles of CRISPR systems. Research interests include: CRISPR-Cas Systems Anti-CRISPR Proteins Bacterial Cell Wall Synthesis Phage-Bacteria Coevolution RNA-Guided Immunity High-Throughput Genetic Screens Recent publications highlight discoveries in: CRISPR-Cas13 dormancy and resuscitation pathways (2019–2023). Anti-CRISPR protein mechanisms (2020, 2022). Phage-encoded escape strategies (2016, 2021). Cell wall synthesis in Bacillus subtilis (2013–2016). Lab members include: Postdocs: Shally Margolis, Shoshanna Kahne. PhD Students: Marshall Godsil, Sarina Kao, Amanda Antoch, Edith Sawyer, Luke Oriolt, Alison Ciling. Research Scientists: Maddie Williams, Mark Katz. Collaborations extend to the Guo Lab, focusing on joint PhD training programs.

Kevin WilliamsView profile

Professor

• Atherosclerosis
• Lipoproteins
• Cardiovascular Disease
• +4 more

Kevin Williams, MD is a Professor in the Department of Cardiovascular Sciences at the Lewis Katz School of Medicine, Temple University, with secondary appointments in Medical Genetics and Molecular Biochemistry. He directs research at the Aging + Cardiovascular Discovery Center and serves as principal investigator for multiple NIH-funded projects. His educational credentials include: MD from Johns Hopkins University (1980) Internal Medicine Residency at University of Chicago Medical Center (1983) Clinical Endocrinology Fellowship at Yale-New Haven Hospital (1984) Metabolism Fellowship at Columbia University (1985) Dr. Williams' research revolutionized understanding of atherosclerosis through his work on LDL retention in arterial walls, establishing foundational links between basic science and clinical approaches. His laboratory investigates diabetic dyslipidemia mechanisms and insulin-signaling proteins, emphasizing that atherosclerosis causes 50% of Western deaths and 80% of diabetic cardiovascular events. Current work addresses lipid metabolism in autoimmune diseases and cancer. His 2025 publications reveal intensified focus on cardiovascular risk in lupus/dermatomyositis patients, lipid dysregulation in obesity/cancer, and novel therapeutic targets like SCD inhibition. The work spans molecular mechanisms to clinical management, with strong emphasis on translational applications for high-risk populations. Dr. Williams serves as Consulting Editor for the Journal of Clinical Investigation and on editorial boards for Arteriosclerosis, Thrombosis and Vascular Biology and Rambam Medical Journal. He holds 11 patents related to lipoprotein modification and diabetic dyslipidemia treatment. His laboratory at Temple investigates corrective strategies for postprandial lipid disposal defects in diabetes and explores membrane lipid remodeling in metabolic disease. Current NIH projects focus on early atherosclerotic disease intervention and lipid-based therapeutic approaches for high-risk cardiovascular patients.

Thibault TricardView profile

Associate Professor

• Computer Graphics
• Procedural Modeling
• 3D Printing
• +5 more

Thibault Tricard is an Associate Professor at Ensimag Grenoble and a permanent researcher in the Maverick team at Inria Grenoble. His work bridges Computer Graphics and Additive Manufacturing , focusing on procedural methods for virtual world content generation. His research interests include: Procedural modeling for surface and microstructure details Mesh shaders and GPU-accelerated volume rendering 3D printing optimization with staggered infill structures Recent publications like Interval Shading (HPG 2024) and Procedural Phasor Noise (ACM Siggraph 2020) highlight trends in real-time rendering and fabrication-aware procedural synthesis. Awards include the GDR IG-RV Thesis Award 2023 . He advises PhD students and collaborates with researchers such as Sylvain Lefebvre and Hans-Peter Seidel. Teaching includes GP-GPU High-Performance Computing and 3D Graphics at Inp Grenoble and UGA Mosig. Personal projects like the LavaCake Vulkan library emphasize developer accessibility.

Zhengjie ZhouView profile

Assistant Professor

• Nanomedicine
• Cell Biology
• Translational Medicine
• +7 more

Zhengjie Zhou is an Assistant Professor in the Center for Inflammation and Lung Research (CILR) at the Lewis Katz School of Medicine , Temple University. His work bridges nanomedicine, vascular biology, and pulmonary research to develop cell-targeted therapies for inflammatory lung diseases. Education : PhD in Biochemistry and Molecular Biology from East China Normal University (2013–2018), BS in Pharmacy and Organic Chemistry from Lanzhou University (2009–2013). Research Interests : The Zhou Lab focuses on precise modulation of cell-specific signaling pathways in inflammation and disease. Key areas include: Lung Biology in Inflammation and Injury Nanomedicine and mRNA-loaded Lipid Nanoparticles Endothelial Mechanosensitivity in Vascular Inflammation Scientific Trends : Recent work emphasizes mRNA delivery systems for vascular and lung diseases (2025), targeted nanocarriers for fibrosis (2025), and polyelectrolyte micelles for vascular complications (2021). Earlier studies explore photothermal cancer therapies (2016–2020) and autophagy modulation (2016–2017). Scientific Awards : K99/R00 Pathway to Independence Award (2023) Janet D. Rowley Research Day Award (2022) President Scholarship, ECNU (2017) National Scholarship (2016) Multiple travel awards (2023–2024) Labs & Collaborations : The Zhou Lab is located in the Medical Education & Research Building (Floor 11) , Temple University Medical Campus. It combines molecular biology , nanoparticle engineering , and in vivo models to advance therapies for ARDS, viral pneumonia, and fibrotic disorders.

• Biochemistry
• Molecular Biology
• Medicinal Chemistry
• +7 more

Enyedi Kata Nóra is a Lecturer at the Department of Organic Chemistry , Faculty of Science , ELTE Eötvös Loránd University , Budapest. Her research focuses on peptide-based drug conjugates, molecular targeting in cancer therapy, and structural studies of biologically active molecules. Role: Lecturer Email: kata.nora.enyedi@ttk.elte.hu Address: 1117 Budapest, Pázmány Péter sétány 1/a, Room 448 Research Interests: Enyedi's work spans Biochemistry , Molecular Biology , and Medicinal Chemistry , with a focus on: Design and synthesis of NGR and F3 peptide-drug conjugates Epigenetic regulation via histone variants (H2A.Z) Development of hydrogel systems for cancer cell viability Medical imaging techniques (PET/MRI) for tumor angiogenesis Structural studies of protein stability (Asn/Asp isomerization) Publication Trends: Recent studies emphasize targeted tumor therapy, radiolabeled peptides, 3D hydrogel models, and control peptide design. Key keywords include Drug Delivery , Molecular Imaging , and Peptide Synthesis .

Alastair WarkView profile

Senior Lecturer

• Nanotechnology
• Optical Imaging and Spectroscopy
• Bioanalytical Chemistry
• +7 more

Alastair Wark serves as a Senior Lecturer in Pure And Applied Chemistry at the University of Strathclyde, where he leads research in nanomaterial synthesis, optical imaging, and bioanalytical applications. His multidisciplinary work bridges chemistry, physics, engineering, and medicine to develop novel nanotechnologies for real-time biomolecular monitoring. His research focuses on creating advanced nanomaterials and optical techniques for ultrasensitive detection, including single-particle tracking methods and multimodal imaging systems. Key areas include surface plasmon resonance, shell-isolated nanoparticle spectroscopy (SHINERS), and hybrid nanostructures for cellular interaction studies, contributing significantly to UN Sustainable Development Goals through biomedical applications. His publication trends reveal consistent contributions to nanotechnology and analytical chemistry, with emphasis on single-molecule detection, nanoparticle functionalization, and biomedical sensor development. Recent work integrates prosthetics research through EPSRC-funded projects. Andersonian Centenary Prize (1993) Carnegie Undergraduate Scholarship (1994) He actively supervises PhD students and collaborates across disciplines, evidenced by participation in 22 projects including the EPSRC Centre for Doctoral Training in Prosthetics & Orthotics. His laboratory utilizes specialized equipment including darkfield/fluorescence microscopy and Nanosight systems for nanoparticle characterization, supporting research in complex biological environments.

Montserrat Agut BonsfillsView profile

Professor

• Photodynamic Therapy
• Bioengineering
• Pharmaceutical Sciences
• +4 more

Maria Montserrat Agut Bonsfills is a Professor in the Department of Bioengineering at IQS School of Engineering, specializing in photodynamic therapy (PDT) and antimicrobial applications. Her research focuses on developing targeted delivery systems for photosensitizers, overcoming hypoxia in PDT, and engineering light-activated materials for bacterial and cancer treatments. Current projects: HYPOX (2024-2027), Light4Lungs (2019-2023) Collaborators: Santi Nonell, O. Gulías, R. Bresolí-Obach Her work spans photobiology , nanotechnology , and pharmaceutical sciences , with recent publications emphasizing antimicrobial PDT and multidrug delivery systems . Projects often involve European Commission and AGAUR funding. Key trends in her scientific production include: Antimicrobial photodynamic therapy (82% focus) Photosensitizer engineering (75% focus) Protein-based delivery systems (66% focus) Combination therapies (PDT + chemotherapy) (60% focus) Bacterial and fungal pathogen targeting Environmental applications (water purification) She contributes to Applied Photobiological Chemistry research groups and collaborates across immunology, microbiology, and oncology disciplines.

Maged HenaryView profile

Assistant Professor

• Synthetic Organic Chemistry
• Fluorophore Design
• In Vivo Imaging
• +2 more

Maged Henary is an Assistant Professor at Georgia State University's College of Arts & Sciences, specializing in synthetic organic chemistry with applications in biomedical imaging and cancer therapy. Research focuses on designing near-infrared fluorophores for medical imaging, developing DNA-targeted anticancer agents, and creating sensors for biological applications. Recent work includes fluorophores for endocrine gland imaging, G-quadruplex DNA binders, and pH-sensitive probes. Publication trends show strong emphasis on: Cyanine/squaraine fluorophore design Optoacoustic imaging contrast agents Targeted cancer therapeutics Metal/pH sensing molecules Dr. Henary leads an active research laboratory developing novel imaging agents and maintains collaborations with medical institutions for translational applications.

Andrew T. ArroyoView profile

Adjunct Professor

• Leadership at Minority-Serving Institutions
• Diversity and Inclusion
• Student Success Theory
• +3 more

Andrew T. Arroyo, Ed.D., is an Affiliate Professor in the Department of Educational Leadership and Senior Vice Provost for Academic Affairs at Virginia Commonwealth University's School of Education. He holds a doctorate in higher education from Regent University and advanced degrees in humanities, New Testament studies, and philosophy. His career spans 11 years at a public HBCU, where he reached associate professor rank with tenure, and includes significant central academic affairs leadership roles in two provost's offices. Dr. Arroyo's research focuses on leadership at minority-serving institutions (MSIs), diversity/equity/inclusion practices, and student success theory. He has secured over $3 million in grants for career pathways initiatives targeting marginalized groups and authored/co-authored over two dozen books and articles on MSI-related topics. His work emphasizes institutional transformation, racial equity, and holistic student support systems. Notable achievements include co-creating the UNCF HBCU Consortium for 21st Century Faculty Development and receiving the W. George Selig doctoral fellowship. His publications explore HBCU student persistence models, familial capital utilization, and challenges faced by non-Black students at HBCUs. Current roles involve overseeing academic affairs strategy and faculty development initiatives across VCU's 13 schools and colleges. Education: Ed.D., Higher Education, Regent University M.A., Humanities (Philosophy), Old Dominion University M.A., New Testament Studies, Regent University B.A., Philosophy, Old Dominion University Awards: W. George Selig Doctoral Fellow (2007–2010) Lilly Endowment-funded UNCF Career Pathways Initiative funding UNCF Career Pathways Initiative Award for HBCU Consortium development His professional trajectory includes department chair roles managing large course enrollments and faculty oversight, alongside community revitalization work in distressed urban areas. Dr. Arroyo's interdisciplinary approach bridges academic research and administrative leadership to advance equitable educational outcomes.

Connie Roser-RenoufView profile

Research Professor

• Environmental Communication
• Climate Change Communication
• Informal Science Education
• +3 more

Connie Roser-Renouf is a Research Professor at George Mason University's Department of Communication, affiliated with the Center for Climate Change Communication since its 2007 founding. She holds a PhD in Communication Research from Stanford University (1986). Her work focuses on applying information processing theories to design climate change communication strategies that increase public awareness of climate threats and solutions. She has studied diverse social issues, including Third World development and health risks from environmental contamination, but now prioritizes depolarizing climate change discourse to build public support for action. Education: PhD in Communication Research, Stanford University, 1986 Research Interests: Environmental communication, informal science education, and science communication. She investigates audience segmentation (e.g., Global Warming’s Six Americas framework), emotional responses to climate messaging, and strategies to engage polarized audiences. Her work emphasizes actionable insights for depolarizing climate discourse through tailored messaging and institutional collaboration. Article Trends: Recent publications (2020–2025) highlight longitudinal studies on climate belief shifts, emotional drivers of policy support, and the efficacy of targeted messaging strategies. Her research increasingly incorporates digital platforms (e.g., NASA climate website analysis) and youth engagement. Key themes include depolarization, behavioral activation, and institutional communication models. Awards & Grants: No specific awards mentioned. Her work is supported through institutional and collaborative research funding streams at George Mason University. Advising & Grants: No formal advisees listed. Collaborates on large-scale projects like the Six Americas segmentation framework, funded by organizations such as the National Science Foundation and private foundations. Labs & Teams: Leads climate communication initiatives at the Center for Climate Change Communication, collaborating with interdisciplinary teams across environmental science, public health, and political science.

• Natural Products Chemistry
• Neurological Disease Biology
• High-Throughput Screening
• +3 more

Yun Feng is an Associate Professor at Griffith University's School of Environment and Science, specializing in Chemistry and Forensic Science. She leads research at the Institute for Biomedicine and Glycomics, focusing on natural product chemistry and its applications in neurological disease biology. Her academic journey includes a BSc in Pharmaceutical Chemistry from Peking University (China), a PhD in Marine Natural Products from James Cook University (Australia), and postdoctoral research at the University of Canterbury (New Zealand). Research Interests: Discovery of biologically active natural products using high-throughput screening Neurodegenerative disease mechanisms, particularly neuroprotection via mitochondrial modulation Marine microbial probiotics and their therapeutic potential Anti-inflammatory and antimicrobial compounds from medicinal plants Collaborations and Projects: Leads a Marine Bioproduct CRC project exploring marine microbial probiotics and collaborates with industry partners on natural product drug discovery initiatives. Active in both academic and applied research, her work bridges chemistry, biology, and clinical applications. Teaching & Mentoring: Convenor for undergraduate chemistry courses and former Program Director for the Biomolecular Science Honours program. Supervises PhD and Master’s students in areas like probiotic development, anti-cancer compounds, and Parkinson's disease research. Professional Affiliations: Member of the Griffith Institute for Drug Discovery (2004–2024) and Institute for Biomedicine and Glycomics (2024–present).

Emily MeversView profile

Assistant Professor

• Natural Products
• Drug Discovery
• Chemical Biology
• +3 more

Emily Mevers is an Assistant Professor in the Department of Chemistry at Virginia Tech's College of Science, where she established her research program in August 2020. Her lab investigates ecological metabolomes to discover bioactive natural products with therapeutic potential, focusing on underexplored niches like marine egg masses and millipede secretions. Education: B.S. in Chemistry, University of South Florida (2009) M.S. in Organic Chemistry, University of California San Diego (2011) Ph.D. in Organic Chemistry, University of California San Diego (2014) Postdoctoral Research Fellow, Harvard Medical School (2014-2016) Research Associate, Harvard Medical School (2017-2020) Research Focus: Dr. Mevers employs a function-first discovery approach to isolate natural products evolved for specific ecological roles. Her work centers on marine egg mass microbiomes (seeking predation-deterrent compounds for cancer/infection applications) and deep-sea hydrothermal vent systems (studying electron shuttles for mineral respiration). This integrates chemical ecology , organic synthesis , and microbial physiology to bridge ecological function with drug discovery. Publication Trends: Analysis of her 15 most recent publications reveals dominant themes in millipede defensive chemistry (5 articles), marine egg mass microbiomes (4 articles), and bacterial electron transfer (3 articles). Her work consistently links ecological function to bioactive compound discovery, with increasing focus on computational prediction of redox properties and host-microbe chemical interactions since 2023. Scientific Recognition: American Society of Pharmacognosy Postdoctoral Research Fellow Travel Award (2015) Teddy Traylor Award (2013) David Carew Graduate Student Travel Award (2013) Biochemistry of Growth Regulation and Oncogenesis NIH Trainee (2011-2014) Research Leadership: Dr. Mevers directs the Mevers Lab at Virginia Tech, mentoring graduate students in natural product discovery. Her prior NIH-funded training and current institutional support enable access to advanced instrumentation for metabolomics and bioassay development. She actively collaborates with marine biologists for sample collection and ecologists for functional validation. Research Infrastructure: The lab operates from 3103 Hahn Hall South, utilizing NMR, mass spectrometry, and microbial culturing facilities. Current projects include chemical profiling of marine invertebrate microbiomes, millipede alkaloid biosynthesis studies, and high-throughput screening of redox mediators – all aligned with Virginia Tech's strategic focus on One Health initiatives.